# Amesite Inc.: overview AMST · Nasdaq · CIK 1807166 · [Technology](/sectors/technology.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/amst.md) · [Financials](/companies/amst/financials.md) · [Filings](/companies/amst/filings.md) · [Insiders](/companies/amst/insiders.md) Latest reported revenue: [$79.1k](/filings/0001213900-26-102676.md) for Q4 FY2026, three months to 2026-06-30, from the 10-K filed Sep 23, 2026 (XBRL us-gaap:Revenues, accession 0001213900-26-102676). ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [11.3](/filings/0001213900-25-102257.md) | [12.8](/filings/0001213900-26-012916.md) | [30.7](/filings/0001213900-26-058512.md) | [55.8 d](/filings/0001213900-26-102676.md) | [94.3](/filings/0001213900-25-102257.md) | [108](/filings/0001213900-26-012916.md) | [83.3](/filings/0001213900-26-058512.md) | [79.1 d](/filings/0001213900-26-102676.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(8243.1%)](/filings/0001213900-25-102257.md) | [(8862.6%)](/filings/0001213900-26-012916.md) | [(2240.9%)](/filings/0001213900-26-058512.md) | [(1538.2%) d](/filings/0001213900-26-102676.md) | [(702.2%)](/filings/0001213900-25-102257.md) | [(689.7%)](/filings/0001213900-26-012916.md) | [(820.9%)](/filings/0001213900-26-058512.md) | [(1329.5%) d](/filings/0001213900-26-102676.md) | | Net margin | % | [(8071.5%)](/filings/0001213900-26-058512.md) | [(8790.3%)](/filings/0001213900-26-058512.md) | [(2161.7%)](/filings/0001213900-26-058512.md) | [(1657.1%) d](/filings/0001213900-26-102676.md) | [(681.1%)](/filings/0001213900-26-058512.md) | [(678.0%)](/filings/0001213900-26-058512.md) | [(813.7%)](/filings/0001213900-26-058512.md) | [(1318.6%) d](/filings/0001213900-26-102676.md) | | Diluted EPS | $ per share | [(0.34)](/filings/0001213900-25-102257.md) | [(0.40)](/filings/0001213900-26-012916.md) | [(0.16)](/filings/0001213900-26-058512.md) | not reported | [(0.14)](/filings/0001213900-25-102257.md) | [(0.16)](/filings/0001213900-26-012916.md) | [(0.15)](/filings/0001213900-26-058512.md) | not reported | | Free cash flow | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [697](/filings/0001213900-23-081208.md) | [845](/filings/0001213900-25-000438.md) | [167](/filings/0001213900-25-093213.md) | [110](/filings/0001213900-26-102676.md) | [365](/filings/0001213900-26-102676.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(1299.4%)](/filings/0001213900-23-081208.md) | [(499.9%)](/filings/0001213900-25-000438.md) | [(2744.3%)](/filings/0001213900-25-093213.md) | [(3262.4%)](/filings/0001213900-26-102676.md) | [(861.7%)](/filings/0001213900-26-102676.md) | | Net margin | % | [(1299.8%)](/filings/0001213900-23-081208.md) | [(491.5%)](/filings/0001213900-25-000438.md) | [(2638.5%)](/filings/0001213900-25-093213.md) | [(3274.6%)](/filings/0001213900-26-102676.md) | [(848.7%)](/filings/0001213900-26-102676.md) | | Diluted EPS | $ per share | [(4.67)](/filings/0001213900-23-081208.md) | [(1.68)](/filings/0001213900-25-000438.md) | [(1.73)](/filings/0001213900-25-093213.md) | [(1.03)](/filings/0001213900-26-102676.md) | [(0.63)](/filings/0001213900-26-102676.md) | | Free cash flow | $k | [(6,732)](/filings/0001213900-23-081208.md) | [(3,276)](/filings/0001213900-25-000438.md) | [(2,815)](/filings/0001213900-25-093213.md) | not reported | [(2,152)](/filings/0001213900-26-102676.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/amst/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Focus Partners Wealth](/funds/1542153.md) | 2026-06-30 | $222.6k | 167,376 | | Added +1,360 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $79.0k | 59,423 | | New +59,423 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $43.5k | 32,682 | | Reduced −20,897 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $42.0k | 31,595 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $40.2k | 30,201 | | Unchanged | | [Warberg Asset Management LLC](/funds/1597506.md) | 2026-06-30 | $19.0k | 14,287 | | New +14,287 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $18.3k | 13,761 | | Unchanged | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $17.0k | 12,760 | | New +12,760 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $13.4k | 10,100 | | New +10,100 | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $13.3k | 10,000 | | Unchanged | ## Recent filings [All 361 filings](/companies/amst/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-14 | 20:10 ET | [DEF 14A](/filings/0001213900-26-109433.md) | Proxy statement, period 2026-12-10 | 0001213900-26-109433 | | 2026-09-23 | 20:58 ET | [10-K](/filings/0001213900-26-102676.md) | Annual report, period 2026-06-30 | 0001213900-26-102676 | | 2026-09-17 | 20:25 ET | [8-K](/filings/0001213900-26-100973.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001213900-26-100973 | | 2026-09-11 | 21:16 ET | [8-K](/filings/0001213900-26-099345.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-099345 | | 2026-07-20 | 20:30 ET | [8-K](/filings/0001213900-26-079637.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-079637 | | 2026-07-13 | 21:22 ET | [8-K](/filings/0001213900-26-077666.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-077666 | | 2026-06-03 | 21:29 ET | [DEF 14A](/filings/0001213900-26-064849.md) | Proxy statement, period 2026-07-13 | 0001213900-26-064849 | | 2026-05-26 | 20:15 ET | [S-1/A](/filings/0001213900-26-061026.md) | Registration statement, amended | 0001213900-26-061026 | | 2026-05-19 | 12:30 ET | [8-K](/filings/0001213900-26-058740.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-058740 | | 2026-05-18 | 20:46 ET | [10-Q](/filings/0001213900-26-058512.md) | Quarterly report, period 2026-03-31 | 0001213900-26-058512 | ## Latest annual report [Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001213900-26-102676.md), filed Sep 23, 2026. ## Forecast league Q1 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/d296e172-a91b-4b7f-82b8-a37f6dbc1677) ## About the filer - CIK: 1807166 - Tickers: AMST - Exchange: Nasdaq - SIC code: 7372 Services-Prepackaged Software - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.